SelectScience
Join Free
Accelerating Science
NewsClinical Diagnostics

Qiagen Announces New Tests for Cancer Biomarkers

QIAGEN
9 Oct 2010
Sarah Sarah
Marketing / Sales

Product news

QIAGEN launches several tests for cancer companion diagnostics, CE-marked with the Rotor-Gene® Q thermocycler (EGFR) and the PyroMark® pyrosequencing system (EGFR, NRAS, KRAS, BRAF). The new tests are used in personalized healthcare of cancer by identifying certain mutations in these particular genes, which then help clinicians to select and tailor the most appropriate treatment.

The kits are offered as CE-IVD marked therascreen tests in Europe as well as globally for research-use only (RUO), with the CE-marked therascreen pyrosequencing kits available beginning in December 2010.

The new offering expands QIAGEN’s portfolio of companion diagnostics in personalized healthcare; many more kits are currently in development and will be launched over the coming months.

The PCR-based kits can also be used in combination with the highly flexible QIAsymphony RGQ instrument that allows automation of the complete workflow from sample preparation and assay setup through to detection with the Rotor-Gene Q thermocycler. In the near future, pyrosequencing kits will also be automated with the QIAsymphony series.

Links

QIAGENCompany website

Tags

Point-of-CarePoint-of-Care Testing (POCT) or Near Patient Testing (NPT) products are available for urine, blood and other clinical chemistry analyses. POCT includes: blood glucose testing, blood gas and electrolytes analysis, rapid coagulation testing (PT / INR), rapid cardiac markers diagnostics, drugs of abuse screening, urine strips testing, pregnancy testing, fecal occult blood analysis, food pathogens screening, hemoglobin diagnostics, infectious disease testing and cholesterol screening.Clinical TrialsClinical Trials, an essential part of drug discovery process, assess the safety and effectiveness of a new medication or device in the pharmaceutical industry. Clinical Trials are a phased process (Phase 0, Phase I, Phase II, Phase III and Phase IV) which begins after initial preclinical testing.Clinical GeneticsMolecular Genetics covers the analysis of hereditary genetic disease and chromosomal abnormalities. Genetics can be analysed using DNA, RNA, and protein microarrays, PCR, RT PCR and DNA sequencing. Genetic equipment includes genetic workstations, thermal cyclers, cooling blocks and electrophoresis products. Diagnostic kits are used for DNA / RNA extraction and purification.

Related articles

Qiagen Announces New Tests for Cancer Biomarkers